Sanofi has agreed to acquire U.S. biotech company Translate Bio in a $3.2 billion deal, as it wants to strengthen its position in the next-generation mRNA vaccine technology, if we go by a Reuters ...
This prompts a reassessment of the stock’s value to determine if this represents a genuine opportunity or a potential trap.
Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "mRNA Synthesis Raw Materials - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for mRNA ...
NEW ALBANY, OH / ACCESSWIRE / April 16, 2024 / AmplifyBio, a Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) focused on differentiating services ...
Improvements in R&D, manufacturing, and data sharing will extend platform’s reach. Although mRNA was thrust into the spotlight by COVID-19, the potential for this emerging therapeutic modality extends ...
Federal policies under Robert F. Kennedy Jr. that are hostile to vaccines have “sent a chill through the entire industry,” one scientist said.
WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently ...
LUMI-lab, an AI-powered robotic platform trained on 28 million molecules, iteratively optimized lipid nanoparticles and identified brominated lipid tails as strong enhancers of mRNA delivery in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results